- Home
- VRRM vs IRON Comparison
VRRM vs IRON Comparison
Compare VRRM & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRRM
- IRON
- Stock Information
- Founded
- VRRM 1987
- IRON 2017
- Country
- VRRM United States
- IRON United States
- Employees
- VRRM N/A
- IRON N/A
- Industry
- VRRM Transportation Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- VRRM Consumer Discretionary
- IRON Health Care
- Exchange
- VRRM Nasdaq
- IRON Nasdaq
- Market Cap
- VRRM 3.7B
- IRON 3.4B
- IPO Year
- VRRM N/A
- IRON N/A
- Fundamental
- Price
- VRRM $22.56
- IRON $89.84
- Analyst Decision
- VRRM Strong Buy
- IRON Strong Buy
- Analyst Count
- VRRM 4
- IRON 12
- Target Price
- VRRM $28.38
- IRON $108.83
- AVG Volume (30 Days)
- VRRM 1.5M
- IRON 531.4K
- Earning Date
- VRRM 10-29-2025
- IRON 11-06-2025
- Dividend Yield
- VRRM N/A
- IRON N/A
- EPS Growth
- VRRM N/A
- IRON N/A
- EPS
- VRRM 0.32
- IRON N/A
- Revenue
- VRRM $942,717,000.00
- IRON N/A
- Revenue This Year
- VRRM $11.15
- IRON N/A
- Revenue Next Year
- VRRM $7.03
- IRON N/A
- P/E Ratio
- VRRM $70.76
- IRON N/A
- Revenue Growth
- VRRM 8.52
- IRON N/A
- 52 Week Low
- VRRM $19.51
- IRON $30.82
- 52 Week High
- VRRM $27.20
- IRON $95.95
- Technical
- Relative Strength Index (RSI)
- VRRM 36.63
- IRON 64.84
- Support Level
- VRRM $22.53
- IRON $83.00
- Resistance Level
- VRRM $23.27
- IRON $90.39
- Average True Range (ATR)
- VRRM 0.89
- IRON 3.70
- MACD
- VRRM -0.03
- IRON -0.40
- Stochastic Oscillator
- VRRM 20.75
- IRON 74.77
About VRRM Verra Mobility Corporation
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.